cabozantinib
exelixis
['atlantis', 'cabozantinib', 'urothelial', 'mbc']
later today! a randomised, double-blind, phase ii clinical trial of maintenance cabozantinib following chemotherapy for metastatic #urothelialcarcinoma: final analysis of the #atlantis cabozantinib comparison, presented by robert jones, ma, phd, mbchb #asco22 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology